Sandbox:ab

Hypokalemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Hypokalemia from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Algorithm
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Sandbox:ab On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Sandbox:ab All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Sandbox:ab
CDC on Sandbox:ab
Sandbox:ab in the news
Blogs on Sandbox:ab
Directions to Hospitals Treating Hypokalemia
Risk calculators and risk factors for Sandbox:ab

There are productive measures as secondary prevention of hypokalemia in patients who are susceptible more or have ongoing potassium losses based on their potassium level, including:

• Prescribe potassium chloride 20 mg BID: Patients with congestive heart failure and edematous conditions such as cirrhosis have to take it regularly
• Administrate Proton Pomp Inhibitors and H2 blocker drugs. It can inhibit bicarbonate formation in the stomach and its absorption, as well as limiting potassium loss.
• Prescribe potassium-sparing medications, such as Amiloride 1.25-2.5 mg BID

Prevention of hypokalemia in patients using diuretics:

• Administering K-sparing diuretics is the most suitable preventive option. However, hyperkalemia should be considered in patients with diabetes and older cases (PMID: 11539714)

References

Template:WH Template:WS